Ethiopia

CHAMPS in Ethiopia

About our Work

In Ethiopia, we work in two sites in the Oromia region–Harar, which is urban, and Kersa, which is predominantly rural. Two main hospitals serve these demographic regions; we utilize Hiwot Fana University Hospital for our facility-based activities.

 

Our main implementing partner, Haraghe Health Research (HHR) partnership is a joint program established between Haramaya University and the London School of Hygiene & Tropical Medicine. The Ministry of Health is also engaged with the site through the Ethiopian Public Health Institute (EPHI), an independent public health institute, accountable to the government and considered the technical arm of the Ministry of Health. Haramaya University undertakes and publishes research from the site to influence national policy, and the Ministry of Health is currently focusing on improving data use at the local level, as well as for regional and national decision making.

Fast Facts

Harar

Catchment Area

Kersa

Catchment Area

50,000

Population Under Surveillance

131,431

Population Under Surveillance

22/1,000

Under-5 Mortality Rate

81.9/1,000

Under-5 Mortality Rate

11/1,000

Infant Mortality Rate

45/1,000

Infant Mortality Rate

4.1/1,000

Neonatal Mortality Rate

26.2/1,000

Neonatal Mortality Rate

Meet the Directors

Dr. Nega Assefa Kassa

Assistant Professor of Reproductive Health, Maternal and Child Health, Haramaya University,CHAMPS Ethiopia, Site Director

Read Bio

Dr. Nega Assefa Kassa

Assistant Professor of Reproductive Health, Maternal and Child Health, Haramaya University,CHAMPS Ethiopia

Dr. Nega Assefa is a public health expert in reproductive health and maternal and child health. He has supervised and mentored more than 70 Masters and 6 PhD students at Haramaya University. He has also contributed to course work on sexual and reproductive health, family planning, HIV/AIDS, child growth and survival, and nutrition and dietetics. From 2009-2012, Dr. Nega was the chair of the College of Health and Medical Sciences at Haramaya University and since 2014, he spearheads the Research Groups and Partnerships Directorate at Haramaya University.

Dr. Nega’s research focuses on the areas of pregnancy and childbirth, family planning, child growth and development, and infant and child survival, and he has published 45 peer reviewed articles on reputable national and international journals. Since 2007, Dr. Nega has established and led a Health and Demographic Surveillance under Haramaya University. He assists in monitoring demographic and health changes in 190,000 populations in rural and urban areas of Harar and Kersa in Eastern Ethiopia. He has led a Pneumococcal Conjugate Vaccine study, an adolescent health study, a pregnancy outcome study, and a sanitation and hygiene study.

Dr. Nega is an Honorary Associate Professor at the London School of Hygiene and Tropical Medicine (LSHTM) and Consultant Associate Professor at the Harvard School of Public Health. He is a member of the Maternal and Child Health Advisory Group for the Federal Ministry of Health (FMOH) in which he participated in the development of a policy brief for the Maternal and Child Health Directorate of the FMOH, which was released during the 2016 annual meeting. He is a distinguished member of several editorial boards, including the Training and Research Advisory Group for the Ethiopian Public Health Association, the East African Journal of Health and Biomedical Sciences, and the East African Journal of Sciences.

Dr. Anthony Scott

Professor of Vaccine Epidemiology, Director of the Vaccine Center, London School of Hygiene and Tropical Medicine, CHAMPS Ethiopia, Site Director

Read Bio

Dr. Anthony Scott

Professor of Vaccine Epidemiology, Director of the Vaccine Center, London School of Hygiene and Tropical Medicine, CHAMPS Ethiopia

Anthony Scott is a Wellcome Trust Senior Research Fellow in Clinical Science at the KEMRI-Wellcome Trust Research Programme in Kilifi, Kenya and Professor of Vaccine Epidemiology at the London School of Hygiene & Tropical Medicine (LSHTM). He trained in clinical infectious diseases and epidemiology in Oxford and London before moving to Kilifi in 1993, to study the etiology of pneumonia in adults. Apart from 2 years spent at the Centers for Disease Control and Prevention in Atlanta, he has spent the last 25 years in Kenya, studying pneumococcal disease and pneumonia in children and adults, and vaccines to prevent them. He joined LSHTM in 2013 after 15 years based at Oxford University. In addition to his research he has developed a surveillance network for invasive bacterial diseases in East Africa (Netspear) and he co-directs the Kilifi Health and Demographic Surveillance System, the largest population under continuous surveillance in Africa. He works frequently with WHO and GAVI on vaccine preventable diseases and with the Ministry of Health in Kenya on the evaluation of pneumococcal vaccine.

In the UK, he is the Director of the Vaccine Centre at LSHTM, and co-director of a short course in Vaccinology. He is a member of the UK’s Joint Committee on Vaccination and Immunization (JCVI) and Director of the NIHR Health Protection Research Unit in Immunization at LSHTM which involves a portfolio of research on disease burden, vaccine effectiveness, vaccine safety, modelling, cost-effectiveness, vaccine acceptability and policy implementation in collaboration with Public Health England.